9 clinical trials found.
-
A Phase 2 Study of BIO 300 in Patients with COVID-19
COVID-19 is caused by a virus that triggers inflammation of the lungs. This inflammation may damage the lungs and lead to scarring. This scarring causes ... -
Registry of COVID-19 Survivors: Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database
The purpose of this research study is to obtain a better understanding of the structure and functioning of the heart and lungs in those who ... -
NYU Langone Post-COVID Registry
The purpose of this study is to assess clinical characteristics, biomarkers, management, and outcomes of patients with a history of COVID-19 and generate and develop ... -
A Phase 2 Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of TTI-101 in Participants with Idiopathic Pulmonary Fibrosis
This multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical study is designed to evaluate the safety and tolerability of 3 dose levels of TTI-101 vs placebo in ... -
Enhancing Clinical Outcomes in Patients with Nontuberculous Mycobacteria: A Longitudinal Study
The purpose of this study is to observe what happens to patients with non-tuberculous mycobacteria (NTM). NTM are bacteria that may cause infection in the ... -
Exhaled and nasal nitric oxide in children and adults with chronic wet cough
The purpose of this study is to see if we can use non-invasive tests called forced exhaled nitric oxide (FeNO) (a reading that we get ... -
ENCORE - A Randomized Double-Blind Placebo-Controlled Active Comparator Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)
The purpose of this study is to evaluate the effect and safety of amikacin liposome inhalation suspension (ALIS) treatment on patient-reported symptoms in patients newly ... -
Lung and Diaphragm Ultrasound in Dyspneic Patients
Shortness of breath is one of the most common symptoms experienced by patients with lung conditions. Patients with shortness of breath frequently undergo many tests ... -
Efficacy Safety and Tolerability of BI 1291583 QD Over at least 24 Weeks in Patients with Bronchiectasis
This study is being done to see if the study drug called BI 1291583 may help people with bronchiectasis. Participants in the study may receive ...